Cargando…
Development of Epstein–Barr virus-associated lymphoproliferative disorder and hemophagocytic lymphohistiocytosis during long-term lenalidomide maintenance therapy in multiple myeloma
Reactivation of Epstein–Barr virus (EBV) has been considered a very rare event among patients on immunomodulatory drugs (IMiDs) such as lenalidomide, and an association between the two has not well been recognized. We have recently experienced a rare case of multiple myeloma in which the patient had...
Autores principales: | Yoshida, Mina, Morita, Ken, Fukushima, Hidehito, Jona, Masahiro, Nishikawa, Masako, Yatomi, Yutaka, Kishino, Yuya, Iwasaki, Akiko, Ushiku, Tetsuo, Imadome, Ken-Ichi, Honda, Akira, Maki, Hiroaki, Kurokawa, Mineo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Nature Singapore
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9744661/ https://www.ncbi.nlm.nih.gov/pubmed/36510096 http://dx.doi.org/10.1007/s12185-022-03499-2 |
Ejemplares similares
-
Epstein-Barr virus induced hemophagocytic lymphohistiocytosis in X-linked lymphoproliferative disease
por: Sankararaman, Senthilkumar, et al.
Publicado: (2014) -
Reactivation of Hemophagocytic Lymphohistiocytosis Triggered by Antithymocyte Globulin
por: Matsuda, Kensuke, et al.
Publicado: (2017) -
Characterization of Epstein-Barr virus (EBV)-infected cells in EBV-associated hemophagocytic lymphohistiocytosis in two patients with X-linked lymphoproliferative syndrome type 1 and type 2
por: Yang, Xi, et al.
Publicado: (2012) -
Lenalidomide-Associated Hemophagocytic Lymphohistiocytosis With Plasma Cell Phagocytosis
por: Runge, Elliot, et al.
Publicado: (2021) -
Novel ZAP-70-Related Immunodeficiency Presenting with Epstein–Barr Virus Lymphoproliferative Disorder and Hemophagocytic Lymphohistiocytosis
por: Forster, Moriah, et al.
Publicado: (2021)